{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001759186","name":"Coeptis Therapeutics Holdings, Inc.","summary":"Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company operating through subsidiaries including SNAP Biosciences, GEAR Therapeutics, and Coeptis Therapeutics. Its biopharmaceutical division develops cell therapy platforms for cancer, autoimmune, and infectious diseases, including CD38-GEAR-NK, CD38-Diagnostic, SNAP-CAR, and unmodified NK cell therapies. Its technology division provides AI-powered marketing software and robotic process automation tools to optimize business processes.","people":[],"products":[{"name":"CD38-GEAR-NK","type":"platform","description":"Autologous, gene-edited NK cell therapeutic protecting CD38+ NK cells from destruction by anti-CD38 monoclonal antibodies for CD38-related cancers."},{"name":"CD38-Diagnostic","type":"platform","description":"In vitro diagnostic tool to identify cancer patients likely to benefit from anti-CD38 monoclonal antibody therapy; designated FDA Class II device."},{"name":"SNAP-CAR Platform","type":"platform","description":"Universal self-labeling SynNotch CAR platform for programmable antigen-targeting, applicable to hematologic malignancies and solid tumors using T and NK cells."},{"name":"Unmodified Natural Killer Cells (DVX201)","type":"platform","description":"Unmodified NK cell therapy from pooled donor CD34+ cells being investigated for AML and viral infections in Phase 1 clinical trials."},{"name":"AI-powered marketing software","type":"software","description":"AI-driven marketing software designed to optimize business processes and improve operational efficiency."},{"name":"Robotic Process Automation Tools","type":"software","description":"Automation tools to enhance operational capabilities and improve overall business efficiency."}],"partnerships":[{"partner_name":"Deverra Therapeutics Inc.","partnership_type":"licensing","description":"Exclusive license of stem cell expansion and NK cell differentiation platform; asset purchase of two INDs and Phase 1 programs for DVX201.","start_date":null},{"partner_name":"Vy-Gen-Bio, Inc.","partnership_type":"development","description":"Co-development and steering committee agreement for CD38-GEAR-NK and CD38-Diagnostic with 50/50 revenue sharing; later expanded to exclusive worldwide GEAR rights.","start_date":null},{"partner_name":"University of Pittsburgh","partnership_type":"licensing","description":"Exclusive license for SNAP-CAR intellectual property for worldwide development and commercialization, with field expanded to include NK cells in 2023.","start_date":null},{"partner_name":"Fred Hutchinson Cancer Research Center (FHCRC)","partnership_type":"licensing","description":"Non-exclusive sublicense via Deverra for certain assets under FHCRC agreement, with contingent royalty and milestone payments.","start_date":null},{"partner_name":"Karolinska Institute","partnership_type":"development","description":"Scientists at Karolinska Institute conduct development activities for CD38 assets under Vy-Gen oversight.","start_date":null}],"affiliations":[],"origin":{"leaf":"398c0e5f0e8c6802f3009a96d3da4f5daf0c2ff7621de27de44847e207ef3e69","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"3b884c79541ef3ebc8a4b6d2a3006edb6364b183d345279074c118d9b07f071b","parent":"8e827114a8563af4f4b13534c2db71fa217eaa033fd09d1aa4befdfaea9453f2","source":"0001683168-26-002026","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}